Cite
HARVARD Citation
Olson, E. et al. (n.d.). Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease. Vascular medicine. pp. 473-482. [Online].